Immediate Impact
2 by Nobel laureates 19 from Science/Nature 60 standout
Citing Papers
Switching to once-weekly insulin icodec versus once-daily insulin glargine U100 in individuals with basal-bolus insulin-treated type 2 diabetes (ONWARDS 4): a phase 3a, randomised, open-label, multicentre, treat-to-target, non-inferiority trial
2023 Standout
Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin
2023 Standout
Works of Gerhard Seipke being referenced
In Vitro Metabolic and Mitogenic Signaling of Insulin Glargine and Its Metabolites
2010
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Gerhard Seipke | 398 | 347 | 460 | 22 | 715 | |
| U. D. Larsen | 411 | 277 | 396 | 18 | 750 | |
| James E. Shields | 439 | 189 | 224 | 22 | 668 | |
| Dale A. Freeman | 287 | 141 | 128 | 25 | 618 | |
| R. N. P. Singh | 276 | 105 | 617 | 17 | 768 | |
| Linda Whittaker | 624 | 204 | 231 | 19 | 805 | |
| W. J. Pledger | 564 | 76 | 106 | 26 | 831 | |
| Henri Kercret | 318 | 96 | 138 | 22 | 584 | |
| Anders R. Sørensen | 500 | 208 | 213 | 14 | 733 | |
| W.L. van Noort | 360 | 87 | 75 | 30 | 644 | |
| Melanie Walter | 161 | 343 | 312 | 30 | 761 |
All Works
Loading papers...